A clinical briefing for referring GPs on the integrated private pathway from nodule detection to same-day tissue diagnosis and robotic lung-sparing resection — under one consultant, at London Bridge Hospital and Guy's and St Thomas'.
National lung cancer screening has fundamentally changed the profile of patients presenting with pulmonary nodules. The NHS England Lung Cancer Screening Programme (Nature Medicine, March 2026) has now diagnosed 7,193 cancers across over two million invited patients — 63.1% at TNM Stage I. For these patients, five-year survival is 80–90%. For those diagnosed at Stage IV, it falls below 10%.
Median time from GP-requested chest X-ray to CT in the NHS, against a National Optimal Lung Cancer Pathway standard of 72 hours (LungIMPACT RCT, Woznitza et al., Nature Medicine, 2026).
Of lung cancers in England now diagnosed at Stage I or II — up from 32% in 2022. A significant improvement, but 41% still present at Stage IV (NLCA State of the Nation, 2026).
Time to private specialist assessment at London Bridge Hospital or Lister Hospital Chelsea, with CT review and management plan at the first appointment.
For nodules ≤10mm, current standard practice is interval surveillance imaging — appropriate for most low-risk lesions, but not without cost. Months of diagnostic uncertainty carry a real psychological burden for patients, and where a lesion progresses during that period, the stage at diagnosis may be materially worse. Outcomes for Stage II disease are significantly worse than Stage I — and the interval designed to avoid over-investigation can, in the wrong case, narrow the curative window irreversibly.
Every element of the diagnostic and surgical journey is managed by the same consultant. There is no handover between bronchoscopy and surgery, no re-referral, and no loss of information at the threshold between diagnosis and resection.
Initial consultation within 2–3 working days at London Bridge Hospital, Lister Hospital Chelsea, or outreach clinics at Canary Wharf and City of London. Full CT and PET review, risk stratification, and a clear management plan at the first appointment. No GP referral letter is required for private assessment.
Where tissue diagnosis is warranted, ION robotic bronchoscopy is performed at Guy's and St Thomas' — which has carried out over 900 ION procedures in the last 12 months, making it the highest-volume ION centre in the UK — or at London Bridge Hospital, the first private hospital in Europe to offer ION in routine practice. Intraprocedural fluoroscopy confirms tool-in-lesion positioning before biopsy acquisition for every case, frequently supplemented by cone beam CT. Across most ION lists, rapid onsite evaluation (ROSE) places a cytopathologist in the procedure room to provide a preliminary diagnosis before the patient leaves the suite. At the same bronchoscopic session, indocyanine green (ICG) fluorescent dye is deposited at the nodule — creating a persistent intraoperative marker for subsequent surgical localisation.
At the time of robotic surgery, the da Vinci FireFly infrared camera activates the ICG signal intraoperatively, providing real-time fluorescent localisation of the target lesion. This is critical for sub-centimetre and ground-glass dominant nodules that cannot be reliably identified by palpation at thoracoscopy. Lung-sparing segmentectomy is performed wherever oncologically appropriate, supported by two landmark phase III trials — JCOG0802 (Lancet, 2022) and CALGB 140503 (NEJM, 2023) — which confirmed segmentectomy as a validated standard of care for appropriately selected early-stage NSCLC.
The following situations warrant a specialist opinion — not as a default, but as a clear clinical option for patients where earlier certainty would change management.
A solid nodule ≥6mm or part-solid nodule ≥6mm, particularly with suspicious morphological features
Any nodule demonstrating growth on serial imaging, regardless of absolute size
A screen-detected nodule requiring specialist MDT evaluation and consideration of tissue diagnosis
Known or suspected early lung cancer where lung-sparing resection is being considered
A patient seeking a second opinion on surveillance versus intervention for an indeterminate nodule
A patient with significant nodule-related anxiety where diagnostic certainty would directly improve quality of life
Surveillance is entirely appropriate for the majority of low-risk nodules. A specialist opinion is most useful where the balance between surveillance and earlier intervention is genuinely uncertain, or where the patient's clinical or personal circumstances make continued uncertainty difficult to manage.
The service operates within one of the highest-volume thoracic surgical units in the UK, with outcomes confirmed through the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS).
Personal anatomic lung resections in 2024–25 (SCTS confirmed)
Of resections performed robotically or by VATS — minimally invasive approach
ION navigational bronchoscopy procedures at GSTT in the last 12 months — highest-volume ION centre in the UK
Operative survival, GSTT departmental 2023–24, versus 98.5% national benchmark (SCTS)
GSTT departmental data (2023–24): 837 anatomic resections; 57.8% robotic versus 24% national average; 6% wedge resection rate versus 14% national. Departmental data for 2024–25 submitted to SCTS — pending national publication.
Institutional context: Guy’s and St Thomas’ NHS Foundation Trust holds the #1 and #2 positions in the UK in the Newsweek World’s Best Hospitals 2026 ranking, independently assessed across 32 countries. London Bridge Hospital, where Mr Okiror conducts his private thoracic practice, is ranked #10 — the highest-ranked private hospital in the country. Newsweek World’s Best Hospitals 2026 →
Private patients can be seen within 2–3 working days. No GP referral letter is required, though a brief summary of imaging findings is helpful. Insurance authorisation codes are confirmed on first contact.
The full GP clinical briefing document includes the complete evidence base, referral criteria, ION pathway detail, and outcomes data in a format suitable for saving or sharing.
↓ Download GP Briefing PDFOr use the AI referral letter tool to generate a structured referral letter in under 60 seconds.